Catalyst combining reactivity and selectivity could speed drug development

Chemists have long believed that inserting nitrogen—a beneficial ingredient for making many pharmaceuticals and other biologically active molecules—into a carbon-hydrogen bond requires a trade-off between catalyst reactivity and selectivity. But a new manganese-based catalyst developed by University of Illinois chemists has given researchers both in one efficient, lower-cost package.